Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


07.05.2018

1 Aliment Pharmacol Ther
1 Am J Gastroenterol
4 Dig Dis Sci
7 Dis Colon Rectum
1 Gastroenterol Hepatol
2 Gastroenterology
1 Gut
11 Inflamm Bowel Dis
2 J Crohns Colitis
1 J Immunol
1 Lancet Gastroenterol Hepatol
1 Proc Natl Acad Sci U S A
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. SEHGAL P, Colombel JF, Aboubakr A, Narula N, et al
    Systematic review: safety of mesalazine in ulcerative colitis.
    Aliment Pharmacol Ther. 2018 May 3. doi: 10.1111/apt.14688.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  2. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0057.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  3. BAR-GIL SHITRIT A, Cohen Y, Hassin O, Ben Ya'acov A, et al
    Correction to: Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 27. pii: 10.1007/s10620-018-5084.
    PubMed     Text format     Abstract available

  4. UZZAN M
    Concise Commentary: Calling in Your Marker-Rectal CD30-Positive Cells Differentiate Ulcerative Colitis from Crohn's Disease.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5099.
    PubMed     Text format    

  5. ANDERSON A, Ferris LK, Click B, Ramos-Rivers C, et al
    Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5056.
    PubMed     Text format     Abstract available

  6. PERERA LP, Bhandari S, Liu R, Guilday C, et al
    Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5076.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  7. FLESHNER P
    Expert Commentary on Perioperative Management of Biologic and Immunosuppressive Medications in Crohn's Disease.
    Dis Colon Rectum. 2018;61:431-432.
    PubMed     Text format    

  8. LIGHTNER AL, Wang Z, Zubair AC, Dozois EJ, et al
    A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn's Disease: Progress Made and Future Directions.
    Dis Colon Rectum. 2018;61:629-640.
    PubMed     Text format     Abstract available

  9. CHURCH J
    Missing the Boat? Appreciating the Importance of the Pathophysiology of Perianal Crohn's Disease in Guiding Biological and Surgical Therapy.
    Dis Colon Rectum. 2018;61:529-531.
    PubMed     Text format    

  10. HULL TL
    Expert Commentary on the Evaluation and Management of Rectovaginal Fistulas.
    Dis Colon Rectum. 2018;61:24-26.
    PubMed     Text format    

  11. DURAES LC, Schroeder DA, Dietz DW
    Modified Pfannenstiel Open Approach as an Alternative to Laparoscopic Total Proctocolectomy and IPAA: Comparison of Short- and Long-term Outcomes and Quality of Life.
    Dis Colon Rectum. 2018;61:573-578.
    PubMed     Text format     Abstract available

  12. LAM D, Yong E, D'Souza B, Woods R, et al
    Three-Dimensional Modeling for Crohn's Fistula-in-Ano: A Novel, Interactive Approach.
    Dis Colon Rectum. 2018;61:567-572.
    PubMed     Text format     Abstract available

  13. MESSARIS E
    Digestive Tract Damage: A Predictor of Early Surgical Intervention in Patients With Newly Diagnosed Crohn's Disease.
    Dis Colon Rectum. 2018;61:147-148.
    PubMed     Text format    


    Gastroenterol Hepatol

  14. SEBASTIAN DOMINGO JJ
    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    PubMed     Text format     Abstract available


    Gastroenterology

  15. HOWELL KJ, Kraiczy J, Nayak KM, Gasparetto M, et al
    DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
    Gastroenterology. 2018;154:585-598.
    PubMed     Text format     Abstract available

  16. EVERHOV AH, Halfvarson J, Myrelid P, Sachs MC, et al
    Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Gastroenterology. 2018;154:518-528.
    PubMed     Text format     Abstract available


    Gut

  17. TEN HOVE JR, Shah SC, Shaffer SR, Bernstein CN, et al
    Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study.
    Gut. 2018 May 2. pii: gutjnl-2017-315440. doi: 10.1136/gutjnl-2017-315440.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  18. RAMOS GP, Stroh G, Al-Bawardy B, Faubion WA, et al
    Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987150. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. BURKE KE, Khalili H, Garber JJ, Haritunians T, et al
    Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990575. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. LEWIS JD
    Inflammatory Bowel Disease Care: What to Do When There Is a Breach of Contract between the Patient and Physician?
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990352. doi: 10.1093.
    PubMed     Text format     Abstract available

  21. WU B, Wang Z, Zhang Q
    Cost-Effectiveness of Different Strategies for the Treatment of Moderate-to-Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 27. pii: 4989472. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. KATSANOS KH, Kyriakidi K, Skamnelos A, Christodoulou DK, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4990626. doi: 10.1093.
    PubMed     Text format    

  23. THEODORAKI E, Orfanoudaki E, Foteinogiannopoulou K, Koutroubakis IE, et al
    Asymptomatic hyperCKemia During Infliximab Therapy in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990625. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. CHI LY, Zitomersky NL, Liu E, Tollefson S, et al
    The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 26. pii: 4987131. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. SPENCER EA, Davis SM, Mack DR, Boyle BM, et al
    Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990334. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. OKABAYASHI S, Kobayashi T, Nakano M, Toyonaga T, et al
    A Simple 1-Day Colon Capsule Endoscopy Procedure Demonstrated to be a Highly Acceptable Monitoring Tool for Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Apr 30. pii: 4990576. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. BARBER GE, Hendler S, Okafor P, Limsui D, et al
    Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
    Inflamm Bowel Dis. 2018 May 2. pii: 4990922. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. PATIL SA, Cross RK
    Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Apr 28. pii: 4989997. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Crohns Colitis

  29. LAW CCY, Narula A, Lightner AL, McKenna NP, et al
    Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2018;12:538-545.
    PubMed     Text format     Abstract available

  30. YARLAS A, Rubin DT, Panes J, Lindsay JO, et al
    Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36(R) Health Survey.
    J Crohns Colitis. 2018;12:600-609.
    PubMed     Text format     Abstract available


    J Immunol

  31. ANGELIDOU I, Chrysanthopoulou A, Mitsios A, Arelaki S, et al
    REDD1/Autophagy Pathway Is Associated with Neutrophil-Driven IL-1beta Inflammatory Response in Active Ulcerative Colitis.
    J Immunol. 2018 Apr 30. pii: jimmunol.1701643. doi: 10.4049/jimmunol.1701643.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  32. HORSLEY-SILVA JL, Carey EJ, Lindor KD
    Advances in primary sclerosing cholangitis.
    Lancet Gastroenterol Hepatol. 2016;1:68-77.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  33. DIAS AM, Correia A, Pereira MS, Almeida CR, et al
    Metabolic control of T cell immune response through glycans in inflammatory bowel disease.
    Proc Natl Acad Sci U S A. 2018 May 2. pii: 1720409115.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  34. YADAV A, Foromera J, Falchuk KR, Feuerstein JD, et al
    Biologics and immunomodulators for treating Crohn's disease developing after surgery for an initial diagnosis of ulcerative colitis: a review of current literature.
    Scand J Gastroenterol. 2018 May 2:1-5. doi: 10.1080/00365521.2018.1468478.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: